Aemetis vs its peers
The 8 largest Industrial Organic Chemicals companies by market value, prices of Nov 20, 2026
Aemetis is the 8th largest of the 8 biggest Industrial Organic Chemicals companies on OQRO by market value, at $59.2M. Its revenue of $198M in fiscal 2025 ranks 4th of 8. It runs at an operating loss of 19% of revenue, against a group median margin of −16%. Revenue fell 26% on the year before, against a median of −9.9%.
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Green PlainsGPRE · FY2025 | $796M | $2.09B | −14.9% | +1.7% | 6.5% | −3.2% | −5.8% | 3.5% | — | — | 0.4x | 9.3% | +13.7% |
| Westlake Chemical Partners LPWLKP · FY2025 | $730M | $1.17B | +2.7% | +3.8% | 29.8% | 27.4% | 4.2% | 17.3% | — | 15.0x | 0.6x | 27.6% |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- WLKP27%
- ALTO1%
- GPRE−3%
- GEVO−13%
- AMTX−19%
- FF−55%
- CDXS−59%
- LODE−2455%
Revenue growth, latest year
Compare Aemetis head to head
Where Aemetis’s revenue comes from and where it goes: Aemetis revenue breakdown. Twenty years of results: Aemetis financial history.
Common questions
Who are Aemetis's competitors?
The largest companies in its industry (Industrial Organic Chemicals) by market value: Green Plains (GPRE), Westlake Chemical Partners LP (WLKP), Gevo (GEVO), Alto Ingredients (ALTO), Futurefuel (FF), Codexis (CDXS) and Comstock (LODE). They share Aemetis's industry listing; not every one competes with it on every product.
Is Aemetis bigger than Green Plains?
No, by market value: Aemetis is worth $59.2M and Green Plains $796M. By revenue, Aemetis brought in $198M in fiscal 2025 and Green Plains $2.09B in fiscal 2025.
How does Aemetis's valuation compare with its peers?
Aemetis trades at 0.3x its annual revenue. The median of the other 7 companies is 1.3x revenue and 16.2x earnings. A higher ratio means investors pay more for each dollar the company makes today, usually because they expect it to grow faster.
Where these figures come from
The group is the companies OQRO lists in the same industry as Aemetis (Industrial Organic Chemicals), the largest 7 by market value, plus Aemetis. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.





